Drug intelligence / Profile preview

Bicogreen S-tablet

Development stage
Unknown
Lead developer
Kolon Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Bicogreen S-tablet is an over-the-counter (OTC) enteric-coated combination tablet developed and marketed by KOLON Pharma for the relief of constipation and associated symptoms such as abdominal bloating, loss of appetite, and hemorrhoids. The formulation combines three active ingredients with complementary laxative mechanisms: bisacodyl, docusate sodium, and sennoside calcium. Bisacodyl is a stimulant laxative that directly activates the transient receptor potential melastatin 4 (TRPM4) channel in intestinal epithelial cells, triggering a signaling cascade that promotes fluid secretion and colonic peristalsis. Sennoside calcium, a natural anthraquinone glycoside derivative, is metabolized by gut microbiota into active rheinanthrone, which further stimulates colonic motility. Docusate sodium acts as a surfactant stool softener, lowering surface tension to allow water and lipids to penetrate the stool, making it easier to pass.

Brand names
Bicogreen SBicogreen S-tablet
Other names
Bicogreen S Tab.비코그린에스정
02

Targets

TRPM4 (Calcium-activated non-selective cation channel TRPM4)

Beyond the preview

Go deeper on Bicogreen S-tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bicogreen S-tablet.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call